| Literature DB >> 29520785 |
Michael J Curtis1, Steve Alexander2, Giuseppe Cirino3, James R Docherty4, Christopher H George5, Mark A Giembycz6, Daniel Hoyer7,8, Paul A Insel9, Angelo A Izzo3, Yong Ji10, David J MacEwan11, Christopher G Sobey12, S Clare Stanford13, Mauro M Teixeira14, Sue Wonnacott15, Amrita Ahluwalia16.
Abstract
This article updates the guidance published in 2015 for authors submitting papers to British Journal of Pharmacology (Curtis et al., 2015) and is intended to provide the rubric for peer review. Thus, it is directed towards authors, reviewers and editors. Explanations for many of the requirements were outlined previously and are not restated here. The new guidelines are intended to replace those published previously. The guidelines have been simplified for ease of understanding by authors, to make it more straightforward for peer reviewers to check compliance and to facilitate the curation of the journal's efforts to improve standards.Entities:
Mesh:
Year: 2018 PMID: 29520785 PMCID: PMC5843711 DOI: 10.1111/bph.14153
Source DB: PubMed Journal: Br J Pharmacol ISSN: 0007-1188 Impact factor: 8.739